Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Dasatinib
Related studies linked through entity extraction aliases.
Dasatinib for HIV-1 Reservoir Reduction
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Improving Physical Ability and Cellular Senescence Elimination in HIV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Treatment of Previously Treated Glioma With Residual Disease
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Newly-diagnosed Pediatric T-cell ALL Protocol
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
- Status
- RECRUITING
- Phase
- PHASE2
Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Ma-Spore ALL 2020 Study
- Status
- RECRUITING
- Phase
- PHASE2
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE
- Status
- RECRUITING
- Phase
- PHASE2
Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Umbrella Study in R/R PTCL Guided by Molecular Subtypes
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2